Communications
J . Org. Chem., Vol. 62, No. 23, 1997 7907
and the isobutyryl methyl groups of the hydrazide (3 and
4). One weak cross-peak between the phenylalanine NH
proton (19) and the proton at the 6-position of the
aromatic ring (29), which is not consistent with the model
shown in Figure 1, may be an artifact resulting from
coupling between 19 and 20.9b ROEs between the upper
urea proton (30) and the 1,2-diaminoethane backbone
protons (13, 15, and 16) provide evidence that the 1,2-
diaminoethane diurea forms a turn structure. The
presence of moderate-strong ROEs between 30 and at
least three of the backbone protons suggests that the 1,2-
diaminoethane diurea turn comprises multiple conforma-
tions (e.g., two diastereomeric anti conformers of the 1,2-
diaminoethane backbone).4,12
Strong ROEs between the R and NH protons of
adjacent residues (20 and 27, 18 and 21), and large (8.4
3
and 9.2 Hz) J HNR coupling constants, provide evidence
for a â-strand conformation in the phenylalanylleucine
peptide strand.13 Weak-moderate ROEs between the
phenylalanine and leucine NH groups (19 and 27), and
between the leucine NH and leucine methylamide NH
groups (27 and 21), suggest that non-â-strand conformers
may also be present.
In conclusion, these studies show that the 5-amino-2-
methoxybenzoic hydrazide template forms a hydrogen-
bonded antiparallel â-sheet with the phenylalanylleucine
dipeptide in artificial â-sheet 2. Artificial â-sheet 2 is
similar in structure to systems developed by Kemp et al.14
and by Michne and Schroeder.15 These systems also
contain templates that mimic peptide â-strands; however,
the templates are tetracyclic and bicyclic aromatic mol-
ecules. The simplicity of the 5-amino-2-methoxybenzoic
hydrazide template renders it an attractive alternative
to these polycyclic aromatic templates.
F igu r e 1. Model of artificial â-sheet 2 illustrating interstrand
ROEs. The model was generated using MacroModel V5.5 with
the AMBER* force field. The starting geometry (before
minimization) was chosen to reflect the preferred (anti)
conformation of the 1,2-diaminoethane diurea backbone.4,12
The starting conformation of the leucine side-chain was chosen
to reflect measured coupling constants and NOEs; that of the
phenylalanine is largely arbitrary.
regions of some resonances (14 and 14′, 22 and 22′) were
identified through the two-dimensional NMR studies.
The Tr-ROESY studies show long-range ROEs between
the upper (peptidomimetic) and lower (peptide) strands
that are indicative of antiparallel â-sheet structure.11
Most notably, the proton at the 6-position of the aromatic
ring (29) exhibits ROEs to the phenylalanine R-proton
(20) and the leucine side-chain (1, 5, and 7). These ROEs
are shown as arrows in Figure 1. Also noteworthy are
ROEs between the leucine methylamide methyl group (9)
Ack n ow led gm en t. This work was supported by the
National Institutes of Health Grant GM-49076 and
National Science Foundation Grants CHE-9553262 and
CHE-9625674. D.L.H. and E.M.S. thank the National
Institute on Aging for support in the form of a training
grant (National Research Service Award AG00096-12).
J .S.N. thanks the following agencies for support in the
form of awards: the Camille and Henry Dreyfus Foun-
dation (Teacher-Scholar Award), the National Science
Foundation (Presidential Faculty Fellowship), and the
Alfred P. Sloan Foundation (Alfred P. Sloan Research
Fellowship).
(10) 1H NMR of 2 (25 mM in CDCl3, 298 K): 0.66 (d, J ) 6.4 Hz, 3
H, 1), 0.79 (d, J ) 6.3 Hz, 3 H, 2), 1.24 (d, J ) 6.9 Hz, 3 H, 3), 1.27 (d,
J ) 6.9 Hz, 3 H, 4), 1.39 (ddd, J ) 13.3, 9.3, 5.4 Hz, 1 H, 5), 1.48 (ddd,
J ) 13.8, 8.0, 6.2 Hz, 1 H, 6), 1.56-1.48 (m, 1 H, 7), 2.68-2.65 (m, 2
H, 8), 2.68 (d, J ) 4.8 Hz, 3 H, 9), 2.81 (septet, J ) 6.9 Hz, 1 H, 10),
2.85 (dd ABX pattern, J AB ) 13.8 Hz, J AX ) 8.7 Hz, 1 H, 11), 3.00 (dd
ABX pattern, J AB ) 13.8 Hz, J BX ) 7.5 Hz, 1 H, 12), 3.48-3.41 (m, 1
H, 13), 3.56-3.45 (m, 2 H, 14 and 14′), 3.69-3.61 (m, 2 H, 15), 3.92-
3.86 (m, 1 H, 16), 4.05 (s, 3 H, 17), 4.44 (td, J ) 9.2, 5.7 Hz, 1 H, 18),
4.82 (d, J ) 8.4 Hz, 1 H, 19), 4.94 (q, J ) 8.2 Hz, 1 H, 20), 5.80 (br q,
J ) 4.7 Hz, 1 H, 21), 6.96-6.94 (m, 2 H, 22), 6.96 (d, J ) 9.0 Hz, 1 H,
22′), 7.15 (appar d, J ) 7.0 Hz, 2 H, 23), 7.29-7.23 (m, 3 H, 24), 7.36
(appar t, J ) 7.2 Hz, 1 H, 25), 7.40 (appar t, J ) 7.1 Hz, 2 H, 26), 8.28
(d, J ) 9.2 Hz, 1 H, 27), 8.39 (dd, J ) 9.0, 2.8 Hz, 1 H, 28), 8.62 (d, J
) 2.8 Hz, 1 H, 29), 9.92 (s, 1 H, 30), 10.44 (d, J ) 7.0 Hz, 1 H, 31),
10.97 (d, J ) 7.5 Hz, 1 H, 32).
Su p p or tin g In for m a tion Ava ila ble: Synthetic proce-
dures and one- and two-dimensional 1H NMR spectra of
artificial â-sheet 2 (24 pages).
(11)
1H NMR Tr-ROESY cross-peaks for 2 (25 mM in CDCl3, 298
K). (Cross-peaks in the F1 dimension are tabulated for each resonance
in the F2 dimension.) 1: 5 (m), 6 (s), 7 (s), 18 (m), 27 (w), 29 (w). 2: 5
(m), 6 (m), 7 (s), 18 (s), 27 (w). 3: 9 (m), 10 (s). 4: 9 (m), 10 (s). 5: 1 (s),
2 (m), 6 (s), 7 (m), 18 (m), 27 (m), 29 (w). 6: 1 (s), 2 (s), 5 (s), 18 (m),
27 (m). 7: 1 (s), 2 (s), 5 (m), 18 (m), 27 (m), 29 (w). 8: 14 (s), 14’(s). 9:
3 (m), 4 (m), 21 (s). 10: 3 (s), 4 (s), 31 (m). 11: 12 (s), 19 (s), 20 (s), 23
(m). 12: 11 (s), 19 (m), 20 (s), 23 (m). 13: 15 (s), 30 (m). 14: 8 (s), 14’
(s). 14’: 8 (s), 14 (s). 15: 13 (s), 16 (s), 22 (m), 30 (s). 16: 15 (s), 22 (w),
30 (m). 17: 22’ (s). 18: 1 (m), 2 (s), 5 (m), 6 (m), 7 (m), 21 (s), 27 (m).
19: 11 (s), 12 (m), 22 (m), 23 (m), 27 (w), 29 (w). 20: 11 (s), 12 (s), 23
(s), 27 (s), 29 (m). 21: 9 (s), 18 (s), 27 (w). 22: 19 (s), 26 (s). 22’: 17 (s),
28 (s). 23: 11 (s), 12 (s), 19 (m), 20 (s), 24 (s). 24: 23 (s). 26: 22 (s). 27:
5 (m), 6 (m), 7 (m), 18 (m), 19 (m), 20 (s), 21 (w). 28: 22’ (s), 30 (w). 29:
1 (w), 5 (w), 7 (w), 20 (s), 30 (s). 30: 13 (m), 15 (s), 16 (m), 28 (w), 29
(s). 31: 10 (m). 32: 17 (m).
J O971431B
(12) Nowick, J . S.; Mahrus, S.; Smith, E. M.; Ziller, J . W. J . Am.
Chem. Soc. 1996, 118, 1066.
(13) Dyson, H. J .; Wright, P. E. Annu. Rev. Biophys. Biophys. Chem.
1991, 20, 519.
(14) (a) Kemp, D. S.; Bowen, B. R. Tetrahedron Lett. 1988, 29, 5077.
(b) Kemp, D. S.; Bowen, B. R. Tetrahedron Lett. 1988, 29, 5081. (c)
Kemp, D. S.; Bowen, B. R.; Muendel, C. C. J . Org. Chem. 1990, 55,
4650.
(15) Michne, W. F.; Schroeder, J . D. Int. J . Peptide Protein Res. 1996,
47, 2.